EFFICACY AND SAFETY OF THE SELECTIVE PROGESTERONE RECEPTOR MODULATOR (PRM) VILAPRISAN: A SUB-ANALYSIS OF THE ASTEROID 1 TRIAL BY ETHNICITY

被引：0
|
作者：
Bradley, L. D. [1 ]
Groettrup-Wolfers, E. [2 ]
Zvolanek, M.
Petersdorf, K. [3 ]
Seitz, C. [4 ]
机构：
[1] Cleveland Clin, Ob Gyn, Cleveland, OH 44106 USA
[2] Bayer, Pharmacovigilance, Berlin, Germany
[3] Bayer AG, Clin Dev, Berlin, Germany
[4] Bayer AG, Berlin, Germany
来源：
FERTILITY AND STERILITY | 2018年 / 110卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2018.07.190
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-143
引用
收藏
页码：E62 / E62
页数：1
相关论文
共 50 条
  • [31] A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
    Papanicolaou, D. A.
    Ather, S. N.
    Zhu, H.
    Zhou, Y.
    Lutkiewicz, J.
    Scott, B. B.
    Chandler, J.
    JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (06): : 533 - 543
  • [32] Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial
    Arrigo, Mattia
    Biegus, Jan
    Asakage, Ayu
    Mebazaa, Alexandre
    Davison, Beth
    Edwards, Christopher
    Adamo, Marianna
    Barros, Marianela
    Celutkiene, Jelena
    Cerlinskaite-Bajore, Kamile
    Chioncel, Ovidiu
    Damasceno, Albertino
    Diaz, Rafael
    Filippatos, Gerasimos
    Gayat, Etienne
    Kimmoun, Antoine
    Lam, Carolyn S. P.
    Metra, Marco
    Novosadova, Maria
    Pagnesi, Matteo
    Pang, Peter S.
    Ponikowski, Piotr
    Saidu, Hadiza
    Sliwa, Karen
    Takagi, Koji
    Ter Maaten, Jozine M.
    Tomasoni, Daniela
    Voors, Adriaan A.
    Cotter, Gad
    Cohen-Solal, Alain
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 1145 - 1155
  • [33] EFFICACY AND SAFETY OF THE SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD, IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS OVER 52 WEEKS IN THE PHASE 2 VOYAGE STUDY
    Dellon, Evan S.
    Collins, Margaret H.
    Bredenoord, Arjan
    Philpott, Hamish
    Biedermann, Luc
    Dulcine, Marjori
    Nguyen-Cleary, Thai
    Su, Chinyu
    Yu, Jin
    Tan, Huaming
    Cataldi, Fabio
    Zheng, Hanzhe
    Wang, Wenjin
    Clax, Pamela
    Woolcott, John
    Hirano, Ikuo
    GASTROENTEROLOGY, 2024, 166 (05) : S146 - S147
  • [34] Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results From the Phase 2 VOYAGE Study
    Dellon, Evan S.
    Collins, Margaret H.
    Bredenoord, Albert J.
    Philpott, Hamish
    Biedermann, Luc
    Dulcine, Marjori
    Thai Nguyen-Cleary
    Su, Chinyu
    Yu, Jin
    Cataldi, Fabio
    Zheng, Hanzhe
    Wang, Wenjin
    Springveld, Natalie V.
    Woolcott, John C.
    Hirano, Ikuo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S330 - S331
  • [35] The Interim Sub-analysis from APEX Part 1+2 Studies; Efficacy and Safety of Dimethyl Fumarate in Treatment-naive Japanese Patients with Relapse-remitting MS
    Mori, M.
    Ohashi, T.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Torii, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 456 - 457
  • [36] The Efficacy and Safety of Selective H1-Antihistamine versus Leukotriene Receptor Antagonist for Seasonal Allergic Rhinitis: A Meta-Analysis
    Xu, Yu
    Zhang, Jixiang
    Wang, Jun
    PLOS ONE, 2014, 9 (11):
  • [37] Respiratory safety signal with oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), vs morphine: a safety analysis of a Phase 2b randomized clinical trial
    Singla, N.
    Minkowitz, H.
    Soergel, D.
    Burt, D.
    Skobieranda, F.
    JOURNAL OF PAIN, 2016, 17 (04): : S82 - S82
  • [38] Efficacy and safety of ponesimod, an oral, selective sphingosine 1-phosphate receptor-1 modulator, in patients with relapsing-remitting multiple sclerosis: results from a phase IIb, randomised, double-blind, placebo-controlled trial
    Olsson, T.
    Boster, A.
    Fernandez, O.
    Freedman, M. S.
    Pozzilli, C.
    Bach, D.
    Berkani, O.
    Mueller, M.
    Sidorenko, T.
    Melanson, M.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 49 - 50
  • [39] EFFICACY AND SAFETY OF THE ORAL SELECTIVE SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR MODULATOR VTX002 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 TRIAL
    Sands, Bruce E.
    Panaccione, Remo
    D'Haens, Geert
    Schreiber, Stefan
    DuVall, Aaron
    Kierkus, Jaroslaw
    Naik, Snehal
    Gilder, Kye
    Yun, Chohee
    Sandborn, William
    Walczak, Michal
    Vermeire, Severine
    Rubin, David T.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    GASTROENTEROLOGY, 2024, 166 (05) : S240 - S240
  • [40] Efficacy and safety of the oral selective sphingosine-1-phosphate-1 receptor modulator VTX002 in moderately to severely active Ulcerative Colitis: results from a randomised, double-blind, placebo-controlled, phase 2 trial
    Sands, B. E.
    Panaccione, R.
    D'Haens, G.
    Schreiber, S.
    DuVall, A.
    Kierkus, J.
    Naik, S.
    Gilder, K.
    Yun, C.
    Sandborn, W. J.
    Walczak, M.
    Vermeire, S.
    Rubin, D. T.
    Peyrin-Biroulet, L.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I4 - I5
12345